ConductScience.org, home

Paper17413699

Antimalarial activity of sera from subjects taking HIV protease inhibitors.

Redmond AM and 6 others. AIDS, 2007. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Antimalarial activity of sera from subjects taking HIV protease inhibitors. Papers, record 17413699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17413699

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimalarial activity of sera from subjects taking HIV protease inhibitors.
PubMed
Journal
AIDS
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Redmond AMAndrew M
2Skinner-Adams TTina
3Andrews KTKatherine T
4Gardiner DLDonald L
5Ray JJohn
6Kelly MMark
7McCarthy JSJames S

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
HIV InfectionsMajor topic
HIV Protease InhibitorsMajor topic
Malaria, FalciparumMajor topic
Animals
Antiretroviral Therapy, Highly Active
Chloroquine
Drug Synergism
Humans
Lopinavir
Plasmodium falciparum
Pyrimidinones
Reverse Transcriptase Inhibitors
Ritonavir
Saquinavir
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
35235480Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections.Expert Opin Ther Targets2022https://conductscience.org/library/papers/35235480PubMed
34532241Prevalence of malaria and clinical profile of febrile HIV infected patients in three HIV clinics in Ivory Coast.Malariaworld J2017https://conductscience.org/library/papers/34532241PubMed
32731386Repurposing Drugs to Fight Hepatic Malaria Parasites.Molecules2020https://conductscience.org/library/papers/32731386PubMed
28770176Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.Front Cell Infect Microbiol2017https://conductscience.org/library/papers/28770176PubMed
27143666Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Clin Infect Dis2016https://conductscience.org/library/papers/27143666PubMed
26053030Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.PLoS One2015https://conductscience.org/library/papers/26053030PubMed
25541998Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.PLoS One2014https://conductscience.org/library/papers/25541998PubMed
23358639Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies.Am J Trop Med Hyg2013https://conductscience.org/library/papers/23358639PubMed
23190222Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.N Engl J Med2012https://conductscience.org/library/papers/23190222PubMed
22835018Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique.Malar J2012https://conductscience.org/library/papers/22835018PubMed
22509297The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.PLoS One2012https://conductscience.org/library/papers/22509297PubMed
22354298Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22354298PubMed
22123685HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22123685PubMed
22076126Drugs for malaria: something old, something new, something borrowed.F1000 Biol Rep2011https://conductscience.org/library/papers/22076126PubMed
21876053In vitro activity of antiretroviral drugs against Plasmodium falciparum.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21876053PubMed
21266539HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites.FASEB J2011https://conductscience.org/library/papers/21266539PubMed
20800626Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.Virus Res2010https://conductscience.org/library/papers/20800626PubMed
20028821Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20028821PubMed
19032102HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.J Infect Dis2009https://conductscience.org/library/papers/19032102PubMed
18443130Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18443130PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17413699

GET https://conductscience.org/api/papers/v1/17413699/authors